RLIP76, a non-ABC transporter, and drug resistance in epilepsy
<p>Abstract</p> <p>Background</p> <p>Permeability of the blood-brain barrier is one of the factors determining the bioavailability of therapeutic drugs and resistance to chemically different antiepileptic drugs is a consequence of decreased intracerebral accumulation. T...
Main Authors: | Awasthi Yogesh C, Cucullo Luca, Singhal Sharad S, Fazio Vince, Hallene Kerri L, Awasthi Sanjay, Dini Gabriele, Janigro Damir |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-09-01
|
Series: | BMC Neuroscience |
Online Access: | http://www.biomedcentral.com/1471-2202/6/61 |
Similar Items
-
RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.
by: Jyotsana Singhal, et al.
Published: (2011-01-01) -
RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
by: Kathryn Leake, et al.
Published: (2012-01-01) -
Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells
by: Dini Gabriele, et al.
Published: (2006-03-01) -
RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients
by: Manguoğlu E, et al.
Published: (2011-01-01) -
Rlip Depletion Suppresses Growth of Breast Cancer
by: Chhanda Bose, et al.
Published: (2020-06-01)